Detalhe da pesquisa
1.
Tuberculosis Preventive Therapy among Persons Living with HIV, Uganda, 2016-2022.
Emerg Infect Dis
; 29(3): 609-613, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36823496
2.
Trends of notification rates and treatment outcomes of tuberculosis cases with and without HIV co-infection in eight rural districts of Uganda (2015 - 2019).
BMC Public Health
; 22(1): 651, 2022 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35382794
3.
A four-year trend in pulmonary bacteriologically confirmed tuberculosis case detection in Kampala-Uganda.
BMC Pulm Med
; 19(1): 91, 2019 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31077178
4.
Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014-2016).
BMC Pulm Med
; 19(1): 124, 2019 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31291943
5.
Trend and outcome of notified children with tuberculosis during 2011-2015 in Kampala, Uganda.
BMC Public Health
; 17(1): 963, 2017 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29258581
6.
Epidemiology of tuberculosis in children in Kampala district, Uganda, 2009-2010; a retrospective cross-sectional study.
BMC Public Health
; 15: 967, 2015 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-26407719
7.
Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis.
BMC Public Health
; 15: 291, 2015 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25880829
8.
The T2 Mycobacterium tuberculosis genotype, predominant in Kampala, Uganda, shows negative correlation with antituberculosis drug resistance.
Antimicrob Agents Chemother
; 58(7): 3853-9, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24777100
9.
The Mycobacterium tuberculosis Uganda II family and resistance to first-line anti-tuberculosis drugs in Uganda.
BMC Infect Dis
; 14: 703, 2014 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25523472
10.
Factors associated with poor treatment outcomes among tuberculosis patients in Kyangwali Refugee Settlement, Uganda, 2016-2017.
PLOS Glob Public Health
; 2(8): e0000152, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36962487
11.
Uganda Public Health Fellowship Program's Contributions to the National HIV and TB Programs, 2015-2020.
Glob Health Sci Pract
; 10(2)2022 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35487554
12.
Addressing the drug-resistant tuberculosis challenge through implementing a mixed model of care in Uganda.
PLoS One
; 15(12): e0244451, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33373997
13.
Adherence to the MDR-TB intensive phase treatment protocol amongst individuals followed up at central and peripheral health care facilities in Uganda - a descriptive study.
Afr Health Sci
; 20(2): 625-632, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33163023
14.
Response to anti-tuberculosis treatment by people over age 60 in Kampala, Uganda.
PLoS One
; 13(12): e0208390, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30566486
15.
Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda.
PLoS One
; 13(5): e0198091, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29847567
16.
Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda.
Infect Genet Evol
; 40: 8-16, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26917365
17.
Anti-tuberculosis drug resistance among new and previously treated sputum smear-positive tuberculosis patients in Uganda: results of the first national survey.
PLoS One
; 8(8): e70763, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23936467
18.
Rates of anti-tuberculosis drug resistance in Kampala-Uganda are low and not associated with HIV infection.
PLoS One
; 6(1): e16130, 2011 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21249225